Research
CJC-1925 No DAC Overview
CJC-1295 No DAC, also referred to as Modified GRF (1-29) or “ModGRF(1-29)”, is a synthetic version of growth hormone-releasing hormone (GHRH) consisting of 30 amino acids. This compound acts as a growth hormone secretagogue (GHS), which means it stimulates the anterior pituitary gland to produce and release more growth hormone. Studies have shown that CJC-1295 No DAC is highly effective in elevating levels of plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in both animals and humans.
CJC-1925 Structure
Molecular Formula: C152H252N44O42
PubChem CID: 91976842
Molecular Weight: 3367.9Â g/mol
Synonyms:Â
- CJC1295 Without DAC
- CJC1295 With DAC
- 446262-90-4
- L-Lysinamide,L-tyrosyl-D-alanyl-L-a-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-a-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-
- CJC-1295
CJC-1925 and Growth Hormone
CJC-1295 stimulates the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in animals and humans. Here are some important points about CJC-1295 and its effects on growth hormone:
- CJC-1295 can increase GH levels in the blood by 2 to 10 times for at least 6 days with a single injection. It also raises IGF-1 levels by 0.5 to 3 times for 9 to 11 days.
- In humans, multiple doses of CJC-1295 can keep IGF-1 levels elevated for up to 28 days.
- The estimated half-life of CJC-1295 in humans is around 6 to 8 days.
- CJC-1295 can prolong the half-life and availability of growth-hormone-releasing hormone 1-29 and promote the secretion of insulin-like growth factor 1.
- Benefits of CJC-1295 include fat loss, muscle growth, and improved sleep.
- CJC-1295 is highly effective for weight loss and muscle building.
References:
CJC-1925 and Infertility
Research conducted in the early 1990s indicates that CJC-1295 and similar analogues of growth hormone-releasing hormone could potentially be beneficial in stimulating ovulation among females experiencing infertility.
References:
